Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Total Debt (2018 - 2019)

10x Genomics' Total Debt history spans 2 years, with the latest figure at $29.7 million for Q4 2019.

  • For Q4 2019, Total Debt changed 0.14% year-over-year to $29.7 million; the TTM value through Dec 2019 reached $29.7 million, changed 0.14%, while the annual FY2019 figure was $29.7 million, 0.14% changed from the prior year.
  • Total Debt for Q4 2019 was $29.7 million at 10x Genomics, roughly flat from $29.7 million in the prior quarter.
  • Across five years, Total Debt topped out at $29.7 million in Q4 2019 and bottomed at $29.7 million in Q4 2018.